← Evidence map

ReviewCancers2026

FGFR2b in Gastric Cancer: Translating a Therapeutic Target into a Reliable Biomarker.

Catalin-Bogdan Satala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 42352398